Allison Tong1, Gopala K Rangan2, Marinella Ruospo3, Valeria Saglimbene4, Giovanni F M Strippoli5, Suetonia C Palmer6, David J Tunnicliffe1, Jonathan C Craig1. 1. Sydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia. 2. Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney, Westmead, NSW 2145, Australia. 3. Medical Scientific Office, Diaverum Academy, Diaverum, Lund, Sweden Department of Translational Medicine, Division of Nephrology and Transplantation, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy. 4. Medical Scientific Office, Diaverum Academy, Diaverum, Lund, Sweden. 5. Sydney School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia Medical Scientific Office, Diaverum Academy, Diaverum, Lund, Sweden Department of Translational Medicine, Division of Nephrology and Transplantation, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy. 6. Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Abstract
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening genetic disorder and has multiple complications including, infection, pain, intracranial aneurysm and kidney failure leading to significantly impaired quality of life and reduced survival. These outcomes are well described, but patient perspectives and experiences of living with ADPKD are under-recognized. METHODS: MEDLINE, Embase, PsycINFO and CINAHL were searched to August 2014. Studies were analyzed using thematic synthesis. RESULTS: From 21 studies (n = 247), we derived five themes: unvalidated pain (medical trivialization, inadequacy of pain management); persisting uncertainties and ambiguities (lacking diagnostic clarity, disempowerment in self-care, unpredictable daily disruptions, inability to plan ahead, financial discrimination); genetic guilt and resentment (blaming parents, self-blame, constant burden of guilt); precariousness in pursuing parenthood (prognostic uncertainty, owning the decision, needing directive counselling); and defining parental responsibility for genetic testing and disclosure (preserving normality, doubting necessity of genetic testing, respecting the child's autonomy and hope in future technologies, facilitating preparedness). CONCLUSIONS: The erratic onset of pain contributes to the substantial unpredictability of daily living and prevents patients from establishing long-term life goals. Decisions about family planning, genetic testing of children and disclosure involves making profoundly difficult judgments about ethical parental responsibility. Patient engagement in pain management, strategies for self-care, counselling to reduce the burden of 'genetic guilt' and specific family planning decision support tools may be priorities for care to improve patient-centred outcomes in ADPKD.
BACKGROUND:Autosomal dominant polycystic kidney disease (ADPKD) is a life-threatening genetic disorder and has multiple complications including, infection, pain, intracranial aneurysm and kidney failure leading to significantly impaired quality of life and reduced survival. These outcomes are well described, but patient perspectives and experiences of living with ADPKD are under-recognized. METHODS: MEDLINE, Embase, PsycINFO and CINAHL were searched to August 2014. Studies were analyzed using thematic synthesis. RESULTS: From 21 studies (n = 247), we derived five themes: unvalidated pain (medical trivialization, inadequacy of pain management); persisting uncertainties and ambiguities (lacking diagnostic clarity, disempowerment in self-care, unpredictable daily disruptions, inability to plan ahead, financial discrimination); genetic guilt and resentment (blaming parents, self-blame, constant burden of guilt); precariousness in pursuing parenthood (prognostic uncertainty, owning the decision, needing directive counselling); and defining parental responsibility for genetic testing and disclosure (preserving normality, doubting necessity of genetic testing, respecting the child's autonomy and hope in future technologies, facilitating preparedness). CONCLUSIONS: The erratic onset of pain contributes to the substantial unpredictability of daily living and prevents patients from establishing long-term life goals. Decisions about family planning, genetic testing of children and disclosure involves making profoundly difficult judgments about ethical parental responsibility. Patient engagement in pain management, strategies for self-care, counselling to reduce the burden of 'genetic guilt' and specific family planning decision support tools may be priorities for care to improve patient-centred outcomes in ADPKD.
Authors: Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres Journal: Nat Rev Dis Primers Date: 2018-12-06 Impact factor: 52.329
Authors: Myrte K Neijenhuis; Wietske Kievit; Ronald D Perrone; Jeff A Sloan; Patricia Erwin; Mohammad Hassan Murad; Tom J G Gevers; Marie C Hogan; Joost P H Drenth Journal: BMC Nephrol Date: 2017-05-25 Impact factor: 2.388
Authors: Daniel Eriksson; Linda Karlsson; Oskar Eklund; Hans Dieperink; Eero Honkanen; Jan Melin; Kristian Selvig; Johan Lundberg Journal: Nephrol Dial Transplant Date: 2017-12-01 Impact factor: 5.992
Authors: Ann M O'Hare; Claire Richards; Jackie Szarka; Lynne V McFarland; Whitney Showalter; Elizabeth K Vig; Rebecca L Sudore; Susan T Crowley; Ranak Trivedi; Janelle S Taylor Journal: Clin J Am Soc Nephrol Date: 2018-07-06 Impact factor: 8.237